Advertisement

Topics

Lynkogen Inc. Company Profile

22:20 EDT 16th July 2018 | BioPortfolio

Alteogen Inc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-dug conjugates, biobetters and biosimilars. Alteogen’s portfolio includes clinical-stage long-acting therapeutic proteins and next-generation ADC, developed by its proprietary NexPTM-fusion and NexMabTM platform technology, respectively. It also develops Herceptin and Eylea biosimilars. The company was founded in 2008 and listed in KOSDAQ (196170.KQ).


News Articles [4 Associated News Articles listed on BioPortfolio]

Lynkogen gets exclusive option to Alteogen's NASH/metabolic disease candidates

Alteogen Inc. granted Lynkogen Inc. the option to license exclusive global rights (excluding South Korea and emerging markets) to develop and commercialize its GLP-1 mimetic and alpha-1 antitrypsin (A...

Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases

Alteogen Inc. (KOSDAQ:196170) and Lynkogen Inc. today announced that they have entered into an exclusive option agreement for the development of Alteogen’s novel GLP-1 mimetic a...

Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion ...

Read more...

Deal Watch Asia Focus: Merck Partners With Alibaba For Entry To Digital Health In China

China’s Everest licenses global rights to Novartis FGFR4 inhibitor, while Altogen and Lynkogen partner in NASH and metabolic disease.   

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Lynkogen Inc.

Alteogen Inc. is a Korea-based biopharmaceutical company that focuses on the development and commercialization of novel biologics such as Antibody-dug conjugates, biobetters and b...

More Information about "Lynkogen Inc." on BioPortfolio

We have published hundreds of Lynkogen Inc. news stories on BioPortfolio along with dozens of Lynkogen Inc. Clinical Trials and PubMed Articles about Lynkogen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lynkogen Inc. Companies in our database. You can also find out about relevant Lynkogen Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...


Corporate Database Quicklinks



Searches Linking to this Company Record